We don't have a date for this course yet. Please contact Sophie MacLeod to register your interest.
This five-day short course for healthcare professionals provides an introduction to genetic research and its use in understanding and treating neuromuscular diseases.
You'll learn about genetic testing and research technologies, from classic Sanger sequencing to next generation sequencing and genome wide association studies.
You'll consider the uses and limitations of new cutting edge genetic technologies, and how and which gene therapy approaches can lead to clinical applications.
The course also includes an introduction into ethical considerations in the context of genetic research and genetic counselling.
This course is run by the UCL Institute of Neurology in Queen Square.
Lecture topics will include:
- Patient-derived stem cells
- Gene therapy - the use of antisense oligonucleotides
- Mouse genetics
- Future of genetics
- Genetic counselling
Who this course is for
This course is for healthcare students and professionals working in:
- biological sciences
- occupational therapy
You should have an upper second-class Bachelor’s degree or equivalent or relevant work experience.
Teaching and structure
The course takes place over five days.
You can take this course as either:
- a standalone short course for CPD purposes
- a 'taster module' that allows you to earn UCL credits which can be used towards a postgraduate qualification at UCL if you enrol within five years
You can find out more about the MSc/PGDip/PGCert Neuromuscular Diseases courses, including entry requirements, on the Institute of Neurology's website.
Assessment, certificates and accreditation
You'll receive a certificate of attendance if you complete the course.
The short course isn't assessed. If you're taking the course as a taster module you'll need to complete coursework and an exam.
The course is accredited for CPD by the Royal Colleges of Physicians.
By the end of this course you should be able to understand:
- the different genetic research methods from Sanger sequencing to next generation sequencing
- the limitations and the potential of these techniques in clinical research
- the strengths and weaknesses of different disease models, the use of induced pluripotent stem cells and their suitability for research
The fees are:
- £700 - short course
- £950 - module
Sign up for short course announcements: Subscribe to the UCL Life Learning newsletter to receive news and updates on courses in your chosen area. (For updates on a specific course, contact the administrator - see 'Contact information'.)
Course information last modified: 29 May 2018, 15:27